Xcout Intel
Beckley Psytech
Beckley Psytech is a UK-based clinical-stage biotechnology company developing psychedelic medicines for psychiatric and neurological disorders. Its programs have included BPL-003, an intranasal formulation of 5-MeO-DMT, intended for conditions such as treatment-resistant depression and alcohol use disorder.
Subscribe to see Beckley Psytech’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Beckley Psytech at a glance
Beckley Psytech is a biotech company headquartered in United Kingdom, founded in 2018. It has raised at least $95M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $80M in August 2021. Xcout tracks 2 named people at Beckley Psytech, including Antonio Camarotti (CEO/Publisher). Xcout recorded 22 job postings from Beckley Psytech in the last 90 days, naming tools such as CrowdStrike, Mimecast, Okta.
Beckley Psytech leadership
- Antonio CamarottiCEO/Publisher
- Katarina CamarottiDiretora-executiva
Beckley Psytech funding rounds
At least $95M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $80M | 8 named | |
| Series A | $15M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Beckley Psytech
Xcout recorded 22 job postings from Beckley Psytech in the last 90 days, from a hiring record Xcout has kept since July 2026.
Tools named in Beckley Psytech's job postings
The weekly hiring trend, the roles and locations behind it — see Beckley Psytech's hiring signals →
Recent Beckley Psytech news
Investors
Tech stack
Beckley Psytech competitors
A few of Beckley Psytech's closest competitors — see the full list of competitors and alternatives →
COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.
AtaiBeckley Inc. has its corporate headquarters located in New York, USA. The biopharmaceutical company is on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments.
Lykos Therapeutics is a biotechnology company developing psychedelic-assisted therapies, particularly MDMA-assisted therapy for post-traumatic stress disorder (PTSD). It works with clinicians and researchers to advance regulated treatments for people with PTSD and related mental-health conditions.
Awakn Life Sciences Inc. is a Canadian biotechnology and mental-health company developing psychedelic-assisted therapeutics, initially focused on ketamine-assisted therapy for alcohol use disorder and other addictions. It also operates or supports clinical and treatment services intended for patients with addiction and related mental-health conditions.
ATAI Life Sciences AG is a biopharmaceutical company headquartered in Munich, Germany, focused on acquiring and developing innovative treatments for mental health disorders.
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
Get Beckley Psytech's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Beckley Psytech? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Beckley Psytech in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access